Chronic Inflammatory Demyelinating Polyneuropathy (“CIDP”) is a rare autoimmune neurological disorder that is caused by demyelination of the peripheral nerves.  It is closely related to Guillain Barre Syndrome or Acute Inflammatory Demyelinating Polyneuropathy (“AIDP”), and is considered by some to be the chronic counterpart to GBS.

CIDP can affect people of all ages.  It is caused by an abnormal immune response and can be triggered by many conditions including infections and vaccinations.  Symptoms can include numbness, tingling, and other odd sensations, especially in the extremities, weakness in the arms and legs, loss of deep tendon reflexes, and fatigue.  Recovery can be complete, however the vast majority of persons suffered chronic residual symptoms.  The risk of relapse with progression of symptoms is present.

Early recognition and treatment is important to preventing permanent damage and preserving functional ability.

Kelley v. Secretary of Health and Human Services was the first vaccine case to award a petitioner compensation for chronic inflammatory demyelinating polyneuropathy (“CIDP”).   

For more information about this and other representative cases tried by Attorney Chin-Caplan, click here or see her Representative Cases above.

Representative Case